EventsThe 1st International Electronic Conference on Clinical Medicine
Published
This submission belongs to the session 4. Infectious Diseases of the event The 1st International Electronic Conference on Clinical Medicine
Published date
15 Sep, 2021
Academic Editor
author-avatarEmmanuel Andrès
Citation
Sávio Benvindo Ferreira, Hélida Maravilha Dantas e Sousa Almeida, Igor de Sousa Oliveira, Antimicrobial Potential Of Hydroxymethylglutaryl-Coa Reductases Inhibitors, in Proceedings of The 1st International Electronic Conference on Clinical Medicine, 15 September–30 September 2021, MDPI: Basel, Switzerland, doi: 10.3390/ECCM-10853
Share
Email
Facebook
Twitter
LinkedIn

Antimicrobial Potential Of Hydroxymethylglutaryl-Coa Reductases Inhibitors

image
1. Teacher Training Center (CFP) - Federal University of Campina Grande - Cajazeiras - Paraíba - Brazil
2. Teacher Training Center (CFP) - Federal University of Campina Grande - Cajazeiras - Paraíba - Brazil.
3. Teacher Training Center (CFP) - Federal University of Campina Grande - Cajazeiras - Paraíba - Brazil., Brazil
Abstract

Bacterial resistance to antibiotics represents a serious and worrying public health problem worldwide. Considering this scenario, the reuse of drugs already known is presented as a quick and less expensive opportunity, being considered an attractive alternative for the development of new drugs and treatments, this study proposes the contemplation of an ecumenical scenario on the antimicrobial potential of statins, in this context, its objective is to carry out a narrative review of the scientific literature, providing a basis for future research and new possibilities in the face of this public health problem. Narrative review was used as a method to conceive the state of the art and support a pertinent appreciation of the theme. To initiate the investigation, a guiding question was prepared to conduct the entire research process, using the PICo strategy (Population / Interest / Context). The scientific literature presents studies that reveal the antimicrobial potential of statins against different bacterial strains. The antibacterial activity appears to be a specific statin / specific bacterium, with an emphasis on simvastatin and atorvastatin, and Gram-positive bacteria, particularly S. aureus, as well as rifampicin adjuvant activity in the fight against mycobacteria.

Keywords
Statins
Hydroxymethylglutaryl-Coa Reductases Inhibitors
Antimicrobian activity.
Manuscript
RISKS ASSOCIATED WITH THE USE OF PSYCHOTROPICS IN PATIENTS DIAGNOSED WITH COVID-19